Natera, Inc.

NTRANASDAQHealthcare● Active

$217.40

+$2.09(+0.97%)

Market Cap$31.1B

P/E Ratio—

52W High$256.36

52W Low$131.811

Avg Volume1.4M

Open$218.25

Beta1.54

Insider Trades Ownership Employees

Natera, Inc. (NTRA) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · NTRA · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

308

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Natera, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

NTRA insider buying and selling by quarter

NTRA insider selling · NTRA insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

866K433K0

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

2029 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · NTRA ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

NTRA executive sell shares · NTRA board member insider trading · NTRA insider trading SEC filing

Showing 97 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	832	$212.42	$177K	149,035	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	2,503	$213.44	$534K	146,532	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	1,300	$214.83	$279K	145,232	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	5,499	$216.13	$1.19M⚡	139,733	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	2,351	$217.04	$510K	137,382	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	1,742	$218.28	$380K	135,640	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	2,758	$219.08	$604K	132,882	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	2,400	$220.19	$528K	130,482	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	2,006	$222.25	$446K	128,476	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	6,500	$223.34	$1.45M⚡	121,976	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	1,443	$223.91	$323K	120,533	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	1,630	$224.99	$367K	118,903	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	6,751	$226.15	$1.53M⚡	112,152	Form 4
Jun 4, 2026	Chapman Steven Leonard CEO AND PRESIDENT · Director	Sale	3,409	$226.97	$774K	108,743	Form 4
Jun 1, 2026	Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS	Sale	1,802	$217.52	$392K	138,841	Form 4
Jun 1, 2026	Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS	Sale	413	$218.84	$90K	138,428	Form 4
Jun 1, 2026	Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS	Sale	213	$219.34	$47K	138,215	Form 4
Jun 1, 2026	Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS	Sale	572	$220.67	$126K	137,643	Form 4
May 29, 2026	Rubin Eric H Director	Award	2,124	—	—	2,129	Form 4
May 26, 2026	Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS	Sale	1,652	$202.84	$335K	140,643	Form 4
May 26, 2026	Fesko John PRESIDENT, CHIEF BUS. OFFICER	Sale	1,438	$202.84	$292K	185,782	Form 4
May 8, 2026	Sheena Jonathan Director	Sale	200	$205.43	$41K	255,452	Form 4
May 8, 2026	Sheena Jonathan Director	Sale	900	$207.24	$187K	254,552	Form 4
May 8, 2026	Sheena Jonathan Director	Sale	700	$208.13	$146K	253,852	Form 4
May 8, 2026	Sheena Jonathan Director	Sale	200	$209.57	$42K	253,652	Form 4

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

832

Price

$212.42

Value

$177K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

2,503

Price

$213.44

Value

$534K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

1,300

Price

$214.83

Value

$279K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

5,499

Price

$216.13

Value

$1.19M ⚡

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

2,351

Price

$217.04

Value

$510K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

1,742

Price

$218.28

Value

$380K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

2,758

Price

$219.08

Value

$604K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

2,400

Price

$220.19

Value

$528K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

2,006

Price

$222.25

Value

$446K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

6,500

Price

$223.34

Value

$1.45M ⚡

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

1,443

Price

$223.91

Value

$323K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

1,630

Price

$224.99

Value

$367K

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

6,751

Price

$226.15

Value

$1.53M ⚡

View Form 4 on SEC.gov

Chapman Steven Leonard

CEO AND PRESIDENT · Director

Sale

Date

Jun 4

3,409

Price

$226.97

Value

$774K

View Form 4 on SEC.gov

Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Sale

Date

Jun 1

1,802

Price

$217.52

Value

$392K

View Form 4 on SEC.gov

Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Sale

Date

Jun 1

413

Price

$218.84

Value

$90K

View Form 4 on SEC.gov

Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Sale

Date

Jun 1

213

Price

$219.34

Value

$47K

View Form 4 on SEC.gov

Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Sale

Date

Jun 1

572

Price

$220.67

Value

$126K

View Form 4 on SEC.gov

Rubin Eric H

Director

Award

Date

May 29

2,124

Price

—

Value

—

View Form 4 on SEC.gov

Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Sale

Date

May 26

1,652

Price

$202.84

Value

$335K

View Form 4 on SEC.gov

Fesko John

PRESIDENT, CHIEF BUS. OFFICER

Sale

Date

May 26

1,438

Price

$202.84

Value

$292K

View Form 4 on SEC.gov

Sheena Jonathan

Director

Sale

Date

May 8

200

Price

$205.43

Value

$41K

View Form 4 on SEC.gov

Sheena Jonathan

Director

Sale

Date

May 8

900

Price

$207.24

Value

$187K

View Form 4 on SEC.gov

Sheena Jonathan

Director

Sale

Date

May 8

700

Price

$208.13

Value

$146K

View Form 4 on SEC.gov

Sheena Jonathan

Director

Sale

Date

May 8

200

Price

$209.57

Value

$42K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About NTRA insider trading

NTRA insider trades

Natera, Inc. (NTRA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Sheena Jonathan (Director), Chapman Steven Leonard (CEO AND PRESIDENT · Director), Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS). Over the past 12 months, 5 insiders have filed transactions with the SEC. NTRA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Natera, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

NTRA insider trading · 5 questions

The insiders of Natera, Inc. (NTRA) include executives and directors such as Sheena Jonathan (Director), Chapman Steven Leonard (CEO AND PRESIDENT · Director), Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

NTRA board member insider tradingwho are NTRA insidersNTRA insider rosterNatera, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026